Previsioni
Il prezzo obiettivo medio degli analisti è 10,63 € (+114,31%). La mediana è 9,11 € (+83,67%).
| Acquista |
6 |
| Mantieni |
1 |
| Vendi |
0 |
Discussioni nella community
Non ci sono ancora discussioni su questo asset.
Avvia discussioneNotizie Vai al feed delle notizie
Butterfly Network jumps sharply after Needham buy recommendation and $10 price target
Butterfly Network develops portable ultrasound systems such as the iQ3 that enable whole-body diagnostics via smartphone and AI-assisted image analysis. On September 22, Needham’s “Buy” rating and $10 price target, together with accelerated adoption of the company’s own AI platform, triggered a massive surge in the share price. The company continues to focus on miniaturization and AI to scale usage in hospitals and care settings. » Altro su finanzen.net
Butterfly Network licenses ultrasound-chip technology to Merge Labs for brain-computer interfaces
Butterfly Network has signed a multi-year license agreement with Merge Labs that gives Merge access to the Poseidon family of Ultrasound-on-Chip technology through Butterfly Embedded, Butterfly’s licensing business. Merge Labs plans to use the semiconductor-based ultrasound platform to develop ultrasound-enabled brain-computer interfaces. The agreement includes upfront and milestone payments, hardware purchase commitments, and ongoing royalties on future revenues; Butterfly will be the exclusive partner for Merge’s CMOS‑MEMS chip‑based ultrasound technology but reserves the right to grant additional licenses. » Altro su de.investing.com
Butterfly Network hits 52-week high at $9.74
The stock of Butterfly Network rose to a 52-week high of $9.74 and is currently trading around $9.77, implying a market capitalization of about $2.57 billion and a 1-year performance of +601.47%. Data from InvestingPro view the stock as significantly above its fair value and point to a high beta of 2.08, indicating considerable volatility. In Q2 2026 the company reported adjusted EPS of -$0.01 (better than expected) on revenue of $15.72 million (below expectations), but raised its full-year outlook and highlighted a record quarter with stronger margins and higher US sales. » Altro su de.investing.com
Butterfly Network advances ultrasound revolution with chip and expanding software platform
Butterfly Network replaces traditional ultrasound crystals with a low-cost silicon microchip, transforming medical imaging. The company is shifting from a hardware provider to a platform, with cloud and AI software revenues already making up more than 40% of sales. A planned push into at-home patient monitoring from late 2026 is expected to open large future markets, but the stock remains speculative. » Altro su finanzen.net
Butterfly Network comments on Midjourney full‑body ultrasound scanner and outlines hardware role
Butterfly Network said the prototype Midjourney scanner integrates 40 Ultrasound‑on‑Chip modules and future versions will scale to many more. CEO Joseph DeVivo described the system as a whole‑body scanner using roughly half a million sensors and over two petaflops of processing power, operating without radiation or magnetic risk and designed for frequent monitoring. Butterfly signaled commercial potential in Midjourney's roadmap and noted a prior co‑development agreement that could yield up to $74 million in payments over five years. » Altro su finance.yahoo.com
Dati finanziari
Nell'ultimo trimestre, Butterfly Network ha registrato ricavi pari a 28,78 Mln € e un utile netto di -11,31 Mln €
| (EUR) | settembre 2026 | YoY |
|---|---|---|
| Ricavi | 28,78 Mln | 57,17% |
| Utile lordo | 21,01 Mln | 756,38% |
| Utile netto | -11,31 Mln | 60,94% |
| EBITDA | -9,63 Mln | 64,33% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 1,34 Mld € |
Numero di azioni | 267,46 Mln |
Massimo/minimo a 52 settimane | 9,30 € - 2,12 € |
| Dividendi | No |
Beta | 2,12 |
Rapporto P/E | -26,22 |
Rapporto PEG | -0,59 |
Rapporto P/B | 7,93 |
Rapporto P/S | 11,91 |
Profilo aziendale
Butterfly Network, Inc., una società di salute digitale, sviluppa, produce e commercializza soluzioni di imaging ad ultrasuoni negli Stati Uniti e a livello internazionale. Offre Butterfly iQ, un sistema ad ultrasuoni portatile per l'intero corpo con una singola sonda; Butterfly iQ+, un dispositivo di imaging ad ultrasuoni point-of-care che si collega a smartphone, tablet e sistemi informatici ospedalieri; e Butterfly Blueprint, una piattaforma ad ultrasuoni a livello di sistema con il software Compass, che si integra nell'infrastruttura clinica e amministrativa di un sistema sanitario. La società fornisce inoltre il sistema Butterfly, che comprende sonde, accessori correlati e abbonamenti software, a sistemi sanitari, medici e fornitori di servizi sanitari attraverso una forza vendite diretta, distributori e il canale eCommerce. Inoltre, offre soluzioni software basate sul cloud per sistemi sanitari, teleguida, tutorial educativi in-app e programmi di formazione formale tramite il software Butterfly Academy, oltre a supporto clinico e servizi. Butterfly Network, Inc. è stata costituita nel 2011 ed ha sede a Guilford, nel Connecticut.
| Nome | Butterfly Network |
| CEO | Joseph DeVivo |
| Sede centrale | Burlington,
ma Stati Uniti |
| Sito web | |
| Settore | Sanità |
| Industria | Attrezzature e forniture sanitarie |
| Quotazione in borsa | 13/07/2020 |
| Dipendenti | 220 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
NYSE | BFLY |